BG
ABBV icon

BlackRock Group’s AbbVie ABBV Stock Holding History

BlackRock Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34,000
Closed -$2.14M – 2973
2016
Q3 		$2.14M Buy
+34,000
New +$2.2M ﹤0.01% 1576

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock Group's ABBV Position: Q4 2016 in Review

BlackRock Group increased its AbbVie (ABBV) stake by 6.8% in Q4 2016, buying an estimated $55.1M and bringing the position to 14,242,346 shares worth $892M. The position accounts for 0.42% of the portfolio, ranked #45.

BlackRock Group first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.18B in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • BlackRock Group held 14,242,346 shares of AbbVie worth $892M as of Q4 2016.
  • BlackRock Group bought 902,083 AbbVie shares in Q4 2016, an estimated $55.1M.
  • AbbVie made up 0.42% of BlackRock Group's portfolio in Q4 2016, its #45 holding.
  • BlackRock Group first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's AbbVie position peaked at $1.18B in Q2 2015.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.